TY  - CHAP
M1  - Book, Section
TI  - Anticoagulation
A1  - Rajasekhar, Anita
A1  - Beyth, Rebecca J.
A2  - Walter, Louise C.
A2  - Chang, Anna
A2  - Chen, Pei
A2  - Harper, G. Michael
A2  - Rivera, Josette
A2  - Conant, Rebecca
A2  - Lo, Daphne
A2  - Yukawa, Michi
PY  - 2021
T2  - Current Diagnosis & Treatment Geriatrics, 3e
AB  - Anticoagulants  are  a  class  of  drugs  essential  for  the  optimal  management  of  many  thromboembolic  and  vascular  disorders  that  are  highly  prevalent  among  older  patients.  Anticoagulants  are  unique  compared  to  most  pharmacologic  agents  because  even  small  deviations  from  “therapeutic  levels”  place  patients  at  risk  for  life-threatening  complications.  While  older  patients  with  multimorbidity  are  particularly  susceptible  to  thrombosis,  they  also  have  higher  risks  of  bleeding  than  the  general  population.  With  the  approval  of  direct  oral  anticoagulants  (DOACs)  for  thrombotic  conditions,  these  agents  are  being  used  more  frequently  than  traditional  anticoagulants  in  the  older  patient  due  to  convenience  and  lower  bleeding  risk  in  the  general  population.  This  chapter  briefly  reviews  current  anticoagulant  therapy  and  focuses  on  the  newer  agents  and  recommendations  for  their  use  in  older  patients.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/25
UR  - accessmedicine.mhmedical.com/content.aspx?aid=1180016813
ER  -